DarioHealth Corp. Cost of Revenue
DarioHealth Corp. (DRIO) reported Cost of Revenue of $1.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-11
- DarioHealth Corp. cost of goods and services sold for the quarter ending 2026-06-30 was $1.99M, a 17.46% decline year-over-year.
- DarioHealth Corp. cost of goods and services sold for the quarter ending 2026-03-31 was $2.38M, a 16.93% decline year-over-year.
- DarioHealth Corp. cost of goods and services sold for the quarter ending 2025-12-31 was $2.43M, a 28.66% decline year-over-year.
- DarioHealth Corp. cost of goods and services sold for the quarter ending 2025-09-30 was $1.99M, a 43.82% decline year-over-year.
- DarioHealth Corp. cost of goods and services sold for fiscal 2025 was $9.69M, a 29.62% decline from fiscal 2024.
- DarioHealth Corp. cost of goods and services sold for fiscal 2024 was $13.77M, a 4.14% decline from fiscal 2023.
- DarioHealth Corp. cost of goods and services sold for fiscal 2023 was $14.37M, a 20.18% decline from fiscal 2022.
- DarioHealth Corp. cost of goods and services sold for fiscal 2022 was $18.00M, a 8.77% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.99M 10-Q · filed 2026-08-11 | $4.37M 10-Q · filed 2026-08-11 | $6.80M derived: sum of 3 quarters · filed 2026-08-11 | $8.79M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $2.38M 10-Q · filed 2026-05-13 | $4.81M derived: sum of 2 quarters · filed 2026-05-13 | $6.80M derived: sum of 3 quarters · filed 2026-05-13 | $9.21M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $4.42M derived: sum of 2 quarters · filed 2026-03-19 | $6.82M derived: sum of 3 quarters · filed 2026-08-11 | $9.69M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $1.99M 10-Q · filed 2025-11-13 | $4.40M derived: sum of 2 quarters · filed 2026-08-11 | $7.27M 10-Q · filed 2025-11-13 | $10.67M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $2.40M 10-Q · filed 2026-08-11 | $5.28M 10-Q · filed 2026-08-11 | $8.68M derived: sum of 3 quarters · filed 2026-08-11 | $12.22M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $2.87M 10-Q · filed 2026-05-13 | $6.27M derived: sum of 2 quarters · filed 2026-05-13 | $9.82M derived: sum of 3 quarters · filed 2026-05-13 | $13.32M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $6.95M derived: sum of 2 quarters · filed 2026-03-19 | $10.45M derived: sum of 3 quarters · filed 2026-03-19 | $13.77M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $3.55M 10-Q · filed 2025-11-13 | $7.04M derived: sum of 2 quarters · filed 2025-11-13 | $10.37M 10-Q · filed 2025-11-13 | $13.86M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $3.50M 10-Q · filed 2025-08-12 | $6.83M 10-Q · filed 2025-08-12 | $10.31M derived: sum of 3 quarters · filed 2025-08-12 | $13.22M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $3.33M 10-Q · filed 2025-05-14 | $6.81M derived: sum of 2 quarters · filed 2025-05-14 | $9.72M derived: sum of 3 quarters · filed 2025-05-14 | $13.80M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $6.39M derived: sum of 2 quarters · filed 2025-03-10 | $10.47M derived: sum of 3 quarters · filed 2025-03-10 | $14.37M 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | $2.91M 10-Q · filed 2024-11-07 | $6.99M derived: sum of 2 quarters · filed 2024-11-07 | $10.88M 10-Q · filed 2024-11-07 | $14.96M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $4.08M 10-Q · filed 2024-08-08 | $7.98M 10-Q · filed 2024-08-08 | $12.05M derived: sum of 3 quarters · filed 2024-08-08 | $16.86M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $3.90M 10-Q · filed 2024-05-15 | $7.97M derived: sum of 2 quarters · filed 2024-05-15 | $12.78M derived: sum of 3 quarters · filed 2024-05-15 | $17.82M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $8.88M derived: sum of 2 quarters · filed 2024-03-28 | $13.93M derived: sum of 3 quarters · filed 2024-03-28 | $18.00M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $4.80M 10-Q · filed 2023-11-02 | $9.85M derived: sum of 2 quarters · filed 2023-11-02 | $13.92M 10-Q · filed 2023-11-02 | $19.40M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $5.04M 10-Q · filed 2023-08-10 | $3.95M 10-Q · filed 2022-08-15 | $9.12M 10-Q · filed 2023-08-10 | $7.09M 10-Q · filed 2022-08-15 | $14.60M derived: sum of 3 quarters · filed 2023-08-10 | $19.40M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $4.07M 10-Q · filed 2023-05-11 | $3.14M 10-Q · filed 2022-05-12 | $9.55M derived: sum of 2 quarters · filed 2023-05-11 | $14.36M derived: sum of 3 quarters · filed 2023-05-11 | $17.39M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $5.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $10.28M derived: sum of 2 quarters · filed 2023-03-09 | $13.32M derived: sum of 3 quarters · filed 2023-03-09 | $16.55M 10-K · filed 2023-03-09 | $12.44M 10-K · filed 2022-03-22 | |||
| 2021-09-30 | $4.80M 10-Q · filed 2022-11-14 | $3.10M 10-Q · filed 2021-11-15 | $7.84M derived: sum of 2 quarters · filed 2022-11-14 | $11.07M 10-Q · filed 2022-11-14 | $7.75M 10-Q · filed 2021-11-15 | $11.36M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $3.03M 10-Q · filed 2022-08-15 | $2.66M 10-Q · filed 2021-08-16 | $5.17M 10-Q · filed 2022-08-15 | $4.65M 10-Q · filed 2021-08-16 | $6.55M derived: sum of 3 quarters · filed 2022-08-15 | $8.04M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $1.99M 10-Q · filed 2022-05-12 | $3.52M derived: sum of 2 quarters · filed 2022-05-12 | $5.01M derived: sum of 3 quarters · filed 2022-05-12 | $6.16M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $3.02M derived: sum of 2 quarters · filed 2022-03-22 | $4.17M derived: sum of 3 quarters · filed 2022-03-22 | $5.06M 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $1.49M 10-Q · filed 2021-11-15 | $2.64M derived: sum of 2 quarters · filed 2021-11-15 | $3.53M 10-Q · filed 2021-11-15 | $4.49M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $1.15M 10-Q · filed 2021-08-16 | $2.04M 10-Q · filed 2021-08-16 | $3.00M derived: sum of 3 quarters · filed 2021-08-16 | $3.99M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $888.00K 10-Q · filed 2021-05-17 | $1.85M derived: sum of 2 quarters · filed 2021-05-17 | $2.84M derived: sum of 3 quarters · filed 2021-05-17 | $4.17M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $958.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $1.95M derived: sum of 2 quarters · filed 2021-03-09 | $3.28M derived: sum of 3 quarters · filed 2021-03-09 | $4.96M 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | $995.00K 10-Q · filed 2020-11-12 | $2.32M derived: sum of 2 quarters · filed 2020-11-12 | $4.00M 10-Q · filed 2020-11-12 | $5.48M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $1.32M 10-Q · filed 2020-08-12 | $3.01M 10-Q · filed 2020-08-12 | $4.49M derived: sum of 3 quarters · filed 2020-08-12 | $5.90M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $1.68M 10-Q · filed 2020-05-12 | $3.16M derived: sum of 2 quarters · filed 2020-05-12 | $4.57M derived: sum of 3 quarters · filed 2020-05-12 | $6.11M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $2.89M derived: sum of 2 quarters · filed 2020-03-17 | $4.42M derived: sum of 3 quarters · filed 2020-03-17 | $5.63M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | $1.41M 10-Q · filed 2019-10-28 | $2.95M derived: sum of 2 quarters · filed 2019-10-28 | $4.15M 10-Q · filed 2019-10-28 | $5.16M derived: sum of 4 quarters · filed 2019-10-28 | ||||
| 2018-06-30 | $1.54M 10-Q · filed 2019-08-13 | $2.74M 10-Q · filed 2019-08-13 | $3.75M derived: sum of 3 quarters · filed 2019-08-13 | $4.85M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $1.20M 10-Q · filed 2019-05-13 | $2.21M derived: sum of 2 quarters · filed 2019-05-13 | $3.31M derived: sum of 3 quarters · filed 2019-05-13 | $4.16M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $2.11M derived: sum of 2 quarters · filed 2019-03-25 | $2.96M derived: sum of 3 quarters · filed 2019-03-25 | $3.86M 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | $1.10M 10-Q · filed 2018-11-13 | $1.95M derived: sum of 2 quarters · filed 2018-11-13 | $2.85M 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $850.00K 10-Q · filed 2018-08-09 | $1.75M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |